Cameron Turtle, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 29,000 shares at $38.24 ($1.1M) on 2020-09-30, disclosed to the SEC on 2020-10-02.
Open-market sale of $1.1M BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.59 | 12,442 | $468K | 42.8% |
| 2 | $37.59 | 12,442 | $468K | 42.8% |
| 3 | $38.24 | 2,058 | $79K | 7.2% |
| 4 | $38.24 | 2,058 | $79K | 7.2% |
| Total | $37.68 avg | 29,000 | $1.1M | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |